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Abstract
An unusual ease is described of a patient with both anti-glomerular basement membrane (GBM) disease and 
anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity (MPO-ANCA) presenting with acute 
renal failure. Four years before a seronegative arthritis of the left wrist was diagnosed. Tests for ANCA by indirect 
immunofluorescence were repeatedly negative. The diagnosis was made by renal biopsy and by testing the serum 
with specific enzyme-linked immunosorbent assays (ELISA) for MPO-ANCA and anti-GBM antibodies. To our 
knowledge, this is the first patient presenting with such findings in the Dutch literature.
Keywords: Acute renal failure; Anti-neutrophil cytoplasmic antibody; Anti-GBM antibodies; Crescentic glomeru­
lonephritis; Seronegative arthritis
1. Introduction
In anti-glomerular basement membrane 
(GBM) disease autoantibodies are found in serum 
directed against an epitope within the globular 
domain of type IV collagen of glomerular, distal 
tubular, and alveolar basement membranes 
(Goodpasture antigen). Most patients present 
with signs and symptoms of a rapidly progressive
* Corresponding author.
glomerulonephritis, sometimes accompanied by 
pulmonary haemorrhage (Goodpasture syn­
drome). The occurrence of anti-GBM disease is 
rare: e.g., in Great Britain the incidence is esti­
mated at 0.5 new cases per million inhabitants 
every year [1]. In recent studies the coexistence of 
anti-GBM and anti-neutrophil cytoplasmic anti­
bodies in patients presenting with rapidly pro­
gressive glomerulonephritis has been shown with 
possible prognostic implications with regard to 
recovery of renal function [2-9]. In this report we 
describe a patient presenting with acute renal 
failure and both anti-GBM and anti-neutrophil
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cytoplasmic autoantibodies with myeloperoxidase 
specificity in her serum.
2, Case report
A 49-year-old woman was admitted to hospital 
with a 4-week history of progressive malaise, nau­
sea, vomiting and haematuria. There was also 
continuous retrosternal pain, not related to physi­
cal exercise or posture. Four years before admis­
sion a chronic monarthritis of the left wrist devel­
oped. Two years later a synovectomy with resec­
tion of the distal ulna was performed, showing a 
chronic aspecific synovitis. Two months before 
admission laboratory tests showed normal renal 
function (serum creatinine 75 ¿imol/1; normal 
60-100 ¿¿mol/1). Six weeks before admission 
treatment with sulphasalazine 1000 mg 2dd was 
started because of an arthritis of the right ankle. 
One week later she noticed haematuria, with 
normal urinary output. Respiratory tract com­
plaints (sinus pain, nasal discharge, cough, 
haemoptysis) were absent. She smoked 5 
cigarettes a day. No history of familial renal or 
rheumatological disease was present. Physical ex­
amination revealed a pale woman with a blood 
pressure of 150/90 mmHg. Neck veins were not 
distended; the lungs were clear. Pericardial rub­
bing was present on cardiac examination. Abdom­
inal examination revealed no abnormalities.
Laboratory tests showed an erythrocyte sedi­
mentation rate > 140 mm, a haemoglobin con­
centration of 5.7 mmol/I, thrombocytosis of 329 
X 109/1 and a normal white cell and differential 
count. The urinary protein excretion was 1.1 g/24 
h. The sediment contained > 100 erythrocytes, 
many rust-cylinders and a few erythrocyte-cylin- 
ders, but no leucocytes. Urine culture was nega­
tive. The serum creatinine concentration had risen 
to 866 ¿¿mol/l; serum urea concentration was 
24.7 mmol/1. The calculated endogenous creati­
nine clearance was 3 m l/m in. Serum sodium, 
potassium, blood glucose, liver functions and 
LDH were normal. Serum calcium was 2.53 
mmol/1, phosphorus 1.69 mmol/1 and serum al­
bumin 34 g/1. Protein electrophoresis revealed 
no paraproteins. Tests for cryoglobulins, rheuma­
toid factors (Waaler-Rose and latex), antinuclear 
and antiperinuclear antibodies were negative. 
Complement factors C3 (1.4 g/1) and C4 (0.31 
g/1) were normal, while C3d was elevated (285%).
Tests for anti-neutrophil cytoplasmic antibod­
ies by indirect immunofluorescence using a rou­
tine procedure (assay previously described by van 
de Woude et al. [10]) were negative twice (per­
formed at Groot Ziekengasthuis and at the Cen­
tral Laboratory of the Netherlands Red Cross 
Blood Transfusion Service (CLB), Amsterdam), 
as were tests performed on a serum sample drawn
2 weeks later (during treatment). However, the 
sandwich (catching) ELISA (as previously de­
scribed by Goldschmeding et a l [11], results ex­
pressed as (arbitrary) ELISA units (EU), cut-off 
level 35 EU) with monoclonal antibodies, used 
for testing the specificity of antibodies, was posi­
tive twice (215 and 217 EU), with specificity for 
anti-myeloperoxidase. A test performed on a 
serum sample drawn 2 weeks later (during treat­
ment) was also positive for MPO-ANCA, with a 
decrease in antibody level (54 EU), All samples 
were also positive for MPO-ANCA in a direct 
ELISA using plates coated with purified antigen, 
thereby excluding false-positive results based on 
cross-reaction with monoclonal antibodies used in 
the catching ELISA (tests performed at CLB).
Cardiac sonography showed some pericardial 
effusion, due to pericarditis. Abdominal sonogra­
phy showed normal-sized kidneys (length right 
kidney 11 cm, left kidney 10 cm), with increased 
echographic density of the renal cortex, equal to 
that of the adjacent liver and spleen. There was 
no evidence of hydronephrosis. X-thorax was nor­
mal. Percutaneous renal biopsy showed in nearly 
all glomeruli a recent extracapillary proliferation 
mixed with fibrin deposits (Fig. 1). One glomeru­
lus showed recent destruction of loops, while 
total glomerular destruction with a granuloma­
tous reaction occurred in another. Some Bow­
man’s capsules and tubular basement membranes 
were disrupted, with extensive necrosis of tubular 
epithelium. Intracapillary proliferation was not 
present. No signs of vasculitis could be found. 
The biopsy material for immunofluorescence did 
not contain glomeruli.
By indirect immunofluorescence on frozen
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with positive anti-MPO ELISA has been de­
scribed before: Weber et al. [5] detected low 
titres of anti-MPO antibodies in 7 out of 23
patients with Goodpasture’s syndrome or anti- 
GBM glomerulonephritis. In these patients indi­
rect IF for ANCA was negative as in ours.
A possible explanation for the simultaneous 
production of both types of antibodies might be 
that anti-GBM antibody production starts after 
injury to the GBM by ANCA-associated glomeru­
lonephritis. The age of our patient, being nearer 
to that of patients with ANCA alone (sixth 
decade) as opposed to patients with anti-GBM 
alone (third decade), would support this hypothe­
sis [3,8]» This is also in accordance with the study 
of O ’Donoghue et al. [4] who reported a strong 
association of double positives with female sex 
and (higher) age as opposed to patients with 
anti-GBM disease alone. In our patient the titre 
of anti-GBM antibodies was rather low. This is in 
accordance with Bosch et al. who detected an 
inverse relationship between anti-GBM antibod­
ies and ANCA titres [3],
As mentioned above, the assay for ANCA by 
indirect immunofluorescence in our patient was 
negative twice. In the study by Bosch et al. [3] a 
diffuse nuclear immunostaining pattern with ad­
ditional endonuclear bands was seen in the indi­
rect IF tests of nearly all patients with anti-MPO 
antibodies. The most probable explanation for 
this discrepancy is a difference in the indirect 
immunofluorescence detection technique for 
ANCA. IIF tests in our patient were performed 
on ethanol-fixed granulocytes. It has been shown 
that anti-MPO positive sera produce a perinu­
clear staining pattern on ethanol-fixed granulo­
cytes and a cytoplasmic staining pattern on for­
malin-fixed granulocytes [14]. Moreover, it has 
been demonstrated that anti-MPO sera that are 
negative on ethanol-fixed granulocytes produce a 
cytoplasmic staining pattern on granulocytes when 
cross-linking fixatives are used [15]. Therefore a 
probable explanation for the negative IIF test in 
our patient could be the loss of antigen and/or 
relevant epitopes during ethanol fixation, in which 
case a IIF test using formalin-fixed granulocytes 
might be a more reliable alternative.
It has been concluded that in anti-GBM dis­
ease ANCA may represent a serological marker 
of good (renal) prognosis. In the study by Bosch 
et al., 4 out of 11 patients (36%) with both 
ANCA and anti-GBM antibodies initially on dial­
ysis recovered satisfactory renal function. Three 
patients died (27%). In contrast, all 13 survivors 
with anti-GBM antibodies alone still required 
dialysis support after treatment, while 9 patients 
(41%) died [3]. In our patient there is no indica­
tion for recovery of renal function. This is in 
accordance with the study by O ’Donoghue et al. 
[4] who found a poor outcome in the double 
positive group (11 patients) with significant mor­
tality (4 patients, 36%) and irreversible renal 
failure (100% requiring dialysis with 9% inde­
pendent renal function at 3 months). Of 53 pa­
tients with anti-GBM alone 34 (64%) required 
dialysis, 23 (44%) having independent renal func­
tion at 3 months. The differences in renal prog­
nosis in the afore-mentioned studies might at 
least partly be due to differences in age between 
the study populations, the patients of Bosch 
(mean age 59 years) being considerably younger 
than those of O ’Donoghue (mean age 73 years). 
Weber et al. also reported a poor renal prognosis 
for patients with combined MPO-ANCA and 
anti-GBM similar to that for patients without 
ANCA antibodies [5].
In our patient because of developing thrombo­
cytopenia combination therapy was stopped after
3 weeks. Since patients with rapidly progressive 
glomerulonephritis may respond after 4 weeks 
[16], it cannot be excluded that renal recovery 
might have occurred if treatment with cyclophos­
phamide and/or plasmapheresis could have been 
continued. However, Herody et al., among others, 
concluded in their study of patients with anti- 
GBM disease that creatininaemia over 600 
/¿mol/1 and circulating anti-GBM antibodies de­
tected by immunofluorescence were features 
which indicated an unfavourable renal course [1].
More extensive extrarenal features in patients 
with combined ANCA and anti-GBM antibodies 
have been reported. The development of pul­
monary disease seems significantly associated with 
smoking [1,4]. As for the interpretation of our 
patient’s arthritis, it is known that rheumatic 
manifestations often precede a fulminant course
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in systemic vasculitis [17]. Furthermore, ANCA 
occur in rheumatoid arthritis (RA): Cambridge et 
al. detected anti-MPO antibodies in 12% of pa­
tients with RA [18]. We were not able to find 
references pointing to a possible association be­
tween anti-GBM disease and arthritis in the liter­
ature. Therefore, at present it can neither be 
demonstrated nor ruled out that the seronegative 
arthritis in our patient is an extrarenal manifesta­
tion of anti-MPO disease.
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